News and Resources
News and resources
IFFIm turns 15
IFFIm marks its 15th birthday this year, just as the COVID-19 pandemic has renewed focus on the importance of its unique frontloading model.
IFFIm increases its most recent bond by US$ 250 million to total US$ 1 billion
IFFIm today increased by US$ 250 million the 1% 5-year vaccine bond it issued in April 2021. The additional proceeds will provide Gavi, the Vaccine Alliance, immediately available funding to support routine immunisation in lower-income countries.
COVAX begins vaccine rollout amid global supply challenges
Camel riders traverse Northern Kenya to spread the word about COVID-19 vaccines. Planes bearing half a million vaccines touch down in Manila. Mongolian villagers gather in a health centre waiting room in Batsumber. Around the world, millions of doses of COVID-19 vaccines have begun arriving through the COVAX Facility in the largest and most rapid g...
Australia increases support for COVAX through new pledges to IFFIm
Australia has made new commitments of long-term funding to IFFIm to support the purchase and distribution of COVID-19 vaccines to 92 lower-income economies. Australian Prime Minister Scott Morrison announced his country has pledged AU$ 50 million to IFFIm for the Gavi COVAX AMC. Australia previously pledged AU$36 million to IFFIm for the AMC, bri...
Monique Barbut, Hassatou N’Sele and Ingrid van Wees to join IFFIm Board of Directors
New board members bring diverse backgrounds in global development and finance London, 1 July 2021 – IFFIm, the International Finance Facility for Immunisation, has appointed three new global development and finance executives to its Board of Directors. Monique Barbut, President of World Wildlife Fund (WWF) France, Hassatou Diop N’Sele, Treasurer...
Sweden makes historic US$ 287 million commitment to IFFIm
On 15 April, at the “One World Protected” event to launch a campaign to raise US $2 billion for the Gavi COVAX Advance Market Commitment, Per Olsson Fridh, Sweden’s Minister for International Development Cooperation announced his country’s US$ 258.1 million (SEK 2.25 billion) in long-term funding to IFFIm to support the purchase and distribution of...
Fatimatou Zahra Diop: trailblazer in finance and vaccine access
Against odds, Fatimatou Zahra Diop has seen opportunities for women rise in Senegal and beyond.
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.